Found: 10
Select item for more details and to access through your institution.
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas.
- Published in:
- Cancer & Metabolism, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40170-022-00281-0
- By:
- Publication type:
- Article
Screening of GPCR drugs for repurposing in breast cancer.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1049640
- By:
- Publication type:
- Article
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3915, doi. 10.3390/ijms24043915
- By:
- Publication type:
- Article
Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-73619-x
- By:
- Publication type:
- Article
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60246-5
- By:
- Publication type:
- Article
Author Correction: Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Spatial mapping of the biologic effectiveness of scanned particle beams: towards biologically optimized particle therapy.
- Published in:
- Scientific Reports, 2015, p. 9850, doi. 10.1038/srep09850
- By:
- Publication type:
- Article
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0281063
- By:
- Publication type:
- Article
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1278, doi. 10.3390/ijms25021278
- By:
- Publication type:
- Article